Table 3. Various outcomes according to the level of blood glucose.
<100 mg/dL | 100–180 mg/dL | >180 mg/dL | P | |
BG before IVT | (n = 35) | (n = 138) | (n = 24) | |
Parenchymal hemorrhage (n, %) | 2 (5.7) | 20 (14.5) | 4 (16.7) | 0.183 |
mRS 0–2 at 3 month | 18 (51.4) | 46 (33.3) | 8 (33.3) | 0.105 |
Death at 3 months | 3 (8.6) | 21 (15.2) | 9 (37.5) | 0.006 |
BG after IVT | (n = 35) | (n = 143) | (n = 28) | |
Parenchymal hemorrhage (n, %) | 1 (2.9) | 19 (13.3) | 7 (25.0) | 0.010 |
mRS 0–2 at 3 month | 24 (68.6) | 49 (34.3) | 3 (10.7) | <0.001 |
Death at 3 months | 1 (2.9) | 21 (14.7) | 11 (39.3) | <0.001 |
Mean BG | (n = 31) | (n = 153) | (n = 23) | |
Parenchymal hemorrhage (n, %) | 1 (3.2) | 18 (11.8) | 8 (34.8) | 0.001 |
mRS 0–2 at 3 month | 20 (64.5) | 54 (35.3) | 3 (13.0) | <0.001 |
Death at 3 months | 1 (3.2) | 22 (14.4) | 10 (43.5) | <0.001 |
Maximal BG | (n = 10) | (n = 147) | (n = 50) | |
Parenchymal hemorrhage (n, %) | 1 (10.0) | 17 (11.6) | 9 (18.0) | 0.254 |
mRS 0–2 at 3 month | 7 (70.0) | 56 (38.1) | 14 (28.0) | 0.024 |
Death at 3 months | 0 | 17 (11.6) | 16 (32.0) | <0.001 |